Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001914060-26-000001
Filing Date
2026-06-03
Accepted
2026-06-03 16:21:16
Documents
1
Effectiveness Date
2026-06-03
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8098
  Complete submission text file 0001914060-26-000001.txt   9354
Mailing Address 3900 N TRAVERSE MOUNTAIN BLVD SUITE 200 LEHI UT 84043
Business Address 3900 N TRAVERSE MOUNTAIN BLVD SUITE 200 LEHI UT 84043 801-550-8088
Biolexis Therapeutics Inc. (Filer) CIK: 0001914060 (see all company filings)

EIN.: 872356131 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-586088 | Film No.: 261060941